Skip to search formSkip to main contentSkip to account menu

HibTITER protein, Haemophilus influenzae

Known as: Hib-titer protein, Haemophilus influenzae, HibTITER 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Bacterial ProteinsHaemophilus B Conjugate VaccineHaemophilus Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Comparative reactogenicity and parental acceptability of pertussis vaccines administered into the ventrogluteal area and anterolateral thigh in children aged 2, 4, 6 and 18 months.
1998
1998
Immunogenicity and safety of Haemophilus influenzae type b conjugate vaccine (HibTITER) and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER (TETRAMUNE) in two-month-old infants.
A study was undertaken to evaluate the safety and immunogenicity of a combination vaccine (TETRAMUNE) of conjugate Haemophilus… 
1997
1997
Immunogenicity of Haemophilus influenzae b conjugate vaccine (HibTITER) and safety of HibTITER and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER in infants two months of age: a…
A study was undertaken to evaluate the safety and immunongenicity of a conjugate Haemophilus influenzae type b (Hib) vaccine… 
1997
1997
Italians ban Hib vaccine in BSE scare
The Italian ministry of health has suspended the use and marketing of a vaccine against Haemophilus influenzae type b (Hib… 
1992
1992
Combined childhood immunizations.
  • P. Paradiso
  • Journal of the American Medical Association (JAMA…
  • 1992
  • Corpus ID: 11689174
To the Editor. —The recent article by Clemens et al 1 states the need for care when assessing potential interference in… 
1991
1991
Biological activity of Hib conjugates.
1991
1991
Antigenuria after immunization with Haemophilus influenzae oligosaccharide CRM197 conjugate (HbOC) vaccine.
We tested the urine of 30 infants 6 weeks to 7 months of age after they received standard 10-micrograms (0.5-ml) doses of HbOC… 
1990
1990
Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
A total of 268 infants aged 15 to 23 months received one dose of a vaccine composed of Haemophilus influenzae type b… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)